Recently, interleukin (IL)-6 was shown to be one of the earliest factors that trigger the differentiation of naive T cells into effector Th2 cells in vitro. Lyme arthritis was studied in IL-6-deficient mice, since joint inflammation is influenced by the T helper cell response against Borrelia burgdorferi. Arthritis incidence increased in B. burgdorferi-infected IL-6-deficient mice compared with that in controls. Furthermore, splenocytes of B. burgdorferi-infected IL-6-deficient mice produced significantly less IL-4 in response to Borrelia antigens than did C57BL/6 (B6) mice, and B. burgdorferi-specific IgG2b levels were significantly reduced in IL-6-deficient mice at 60 days of infection. These results extend previous in vitro observations by demonstrating an in vivo role for IL-6 in the differentiation of CD4 T cells toward a Th2 phenotype and further show that CD4 T cell responses influence murine Lyme arthritis.
produce a lesser IgE and IL-4 mRNA response to Candida albicans infection [10] . We have demonstrated the role of IL-6 in the initiation of Th2 responses in vitro and have shown that CD4 T cells from IL-6-deficient naive mice are not able to mount a Th2 response in vitro in the absence of exogenous IL-4 or IL-6 [11] .
We now examine Lyme disease in IL-6-deficient mice as a model system to determine the role of IL-6 in the differentiation of CD4 T cells in vivo. Since Lyme arthritis is dependent on the type of T cell response mounted against B. burgdorferi, we evaluated the course of infection, disease progression, and the B. burgdorferi-specific immune response in IL-6-deficient mice.
Materials and Methods
Mice, B. burgdorferi, and infections. Six-week-old IL-6-deficient and congenic C57BL/6J (B6) mice were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were maintained in isolator cages and euthanized with carbon dioxide gas. Groups of 5-7 mice were intradermally inoculated on the dorsal thoracic midline with 10 4 clonal N40 spirochetes [2, 12] . Mice were sacrificed at 21 and 60 days after inoculation, representing the acute and resolution phases of the disease, respectively [1] . Blood, spleen, urinary bladder, and ear punches were collected aseptically and cultured in BSK II medium. Joints (knees and tibiotarsi) and hearts were formalin-fixed, paraffin-embedded, sectioned, and, in a double-blind fashion, examined microscopically for arthritis and carditis, as described [3] . Arthritis severity was scored in tibiotarsi on a scale from 0 (no arthritis) to 3 (severe arthritis). Carditis severity was not scored [3] .
Splenocyte purification and in vitro assays. Whole splenocytes were obtained by mechanical disruption and depletion of red blood cells. For the quantitation of B. burgdorferi-specific and concanavalin A (ConA) responses, whole splenocytes/mL were plated in 48-well plates with B. burgdorferi lysate (10 mg/mL) or ConA (4 mg/mL) (ICN Pharmaceuticals, Costa Mesa, CA), in a final volume of 0.5 mL. Supernatants were collected after 3 days, and levels of IFN-g and IL-4 were measured as described [5] . Briefly, 96-well ELISA plates (ICN) were coated with the capture antibody (clones 11B11 and R4-6A2 for IL-4 and IFN-g, respectively, at 2 mg/mL) overnight at 4ЊC. After blocking with PBS plus 10% fetal calf serum (PBS/FCS) for 2 h at room temperature, samples were applied and incubated for 1 h at 37ЊC. The biotinylated detection antibody (clones BVD6-24G2 for IL-4 and X MG1.2 for IFN-g, at 1 mg/mL) was added after washing the plates with PBS plus Tween 20 (0.5% [vol/vol]; PBS/Tween). Quantitation of cytokine levels was done after incubating the plates with horseradish-conjugated streptavidin and adding the substrate for the enzyme (trimethyl benzidine B. burgdorferi-specific antibody titers. B. burgdorferi-specific IgM and IgG subclass levels in the sera from the infected animals were determined by ELISA using rabbit anti-mouse subclassspecific antisera to mouse IgM, IgG1, IgG2a, and IgG2b (Mouse Typer sub-isotyping panel; Bio-Rad Laboratories, Hercules, CA) as follows: An ELISA plate (ICN) was coated overnight at 4ЊC with 0.5 mg/mL B. burgdorferi lysate in coating buffer (bicarbonate buffer, pH 9.6) and blocked for 2 h at room temperature with PBS/ FCS. After two washes with PBS/Tween 20, sera (1/100 or 1/500 dilutions for 21-and 60-day sera, respectively [5] ) were applied and incubated for 1 h at room temperature. Sera from uninfected mice were use as a control. The wells were washed, and the isotypespecific antiserum was applied and incubated for 1 h at room temperature. After four washes, horseradish peroxidase-conjugated goat anti-rabbit IgG was applied and incubated for 1 h at room temperature. Plates were read at 450 nm after adding peroxidase substrate (TMB; Kirkegaard & Perry) and stopping the reaction with TMB 1 Component Stop Solution (Kirkegaard & Perry).
Results
To determine whether IL-6-deficient mice have reduced Th2 responses in vivo and to investigate the role of this cytokine in the polarization of CD4 T cells in vivo, we evaluated Lyme disease in mice lacking endogenous IL-6. We infected 6-weekold IL-6-deficient and wild type congenic B6 mice with B. burgdorferi and analyzed arthritis and carditis at 3 and 8 weeks after infection (the acute and resolution phases of the disease), respectively [1] . B6 mice are susceptible to B. burgdorferi infection but are resistant to the development of arthritis [13, 14] . As expected, at 3 weeks of infection, B6 mice developed very mild or no discernible signs of acute arthritis (consistent with infection in 6-week-old animals). In contrast, the incidence of arthritis was strongly increased in IL-6-deficient mice (5 of 14 mice developed discernible signs of arthritis; x 2 , ). Car-P ϭ .01 ditis was present but mild in both groups of mice, apparently not affected by the lack of IL-6. Six of 12 B6 and 6 of 14 IL-6-deficient mice had carditis.
To determine if the increase in arthritis correlated with a skewing of the immune response to B. burgdorferi, we analyzed the cellular response at 3 weeks to correlate disease with the response mounted against B. burgdorferi. When whole splenocytes were restimulated with B. burgdorferi lysates or ConA, and IFN-g and IL-4 levels were quantitated, we observed a decreased ability of IL-6-deficient mice to produce IL-4 in response to B. burgdorferi (Student's t test, ) and ConA P ϭ .004 ( ) (figure 1B), in agreement with the reported role for P ϭ .01 IL-6 in Th2 differentiation [11] . Conversely, splenocytes from B. burgdorferi-infected, IL-6-deficient mice produced significantly increased levels of IFN-g in response to ConA compared with B6 mice ( ) ( figure 1A ). Nevertheless, IFN-g levels P ϭ .02 detected in response to B. burgdorferi antigens did not vary significantly when we compared IL-6-deficient and B6 mice ( and ng/mL in IL-6-deficient and B6 mice, 1.9 ‫ע‬ 0.7 3.1 ‫ע‬ 1.1 respectively; t test, ) (figure 1A), and subsequent eval-P ϭ .33 uation of IFN-g levels in sera of the infected mice showed no ). P ϭ .57 Similar results were found when splenocytes from 21 day-infected mice were used to extract RNA and reverse transcription-polymerase chain reaction performed for IFN-g and IL-4 (data not shown).
At 60 days of infection, no differences were found in arthritis or carditis between IL-6-deficient and control mice. Prevalence of disease at this time point was similar in both IL-6-deficient and congenic B6 mice (6 of 11 B6 mice and 5 of 11 IL-6-deficient mice had resolving arthritic lesions; 7 of 11 B6 mice and 5 of 11 IL-6-deficient mice had resolving carditis), as was arthritis severity in the tibiotarsal joints ( : B6, mean ‫ע‬ SE ; IL-6-deficient mice, ; ). Both IL-1.0 ‫ע‬ 0.0 1.3 ‫ע‬ 0.3 P ϭ .35 6-deficient and control animals had mild lymphocytic infiltrates in the joints and hearts, consistent with regressing inflammatory lesions.
Discussion
We and others have reported an association between murine Lyme arthritis and the development of polarized CD4 T cell helper responses against B. burgdorferi [4, 5] . We have also demonstrated that CD4 T cells from IL-6-deficient mice have an impaired ability to differentiate into IL-4-producing cells, compared with wild type mice [11] . The results presented here indicate that the lack of endogenous IL-6 during infection with B. burgdorferi affects CD4 T cell differentiation and arthritis development. These results also support previous observations that the type of T helper cell response mounted against B. burgdorferi influences arthritis but not carditis [15] . Ruderman et al. [15] have shown that early Lyme carditis is independent of MHC class II CD4 T cell interactions. Their studies indicated that carditis is related to the direct recruitment and activation of macrophages (the predominant cell type in Lyme carditis) and, therefore, is not influenced by antigen presentation or CD4 T cell differentiation. However, experiments suggest a role for T helper cell responses in Lyme arthritis [4, 5] , for the administration of monoclonal antibodies against IFN-g-or IL-12-reduced joint swelling [4] and arthritis severity [5] . In contrast, carditis was not affected by IL-12 monoclonal antibody treatment [5] .
Our results also indicate that, in contrast to the development of acute arthritis, arthritis resolution is not affected by the type of CD4 T cell response mounted against the spirochete. Arthritis may evolve more rapidly in IL-6-deficient than in congenic B6 mice because of an ineffective early response (21 days) that is likely to normally inhibit dissemination of spirochetes to joints. The fact that the 2 groups eventually developed arthritis (60 days), which was resolving in both, without apparent differences in severity indicates that a proper response eventually takes place. These data agree with our previous report, indicating that reduced Th1 responses do not influence the regression of Lyme arthritis [5] . Arthritis resolution is dependent on the production of antibodies against B. burgdorferi [3] , and IL-6-deficient mice produce B. burgdorferi-specific IgG and IgM levels similar to those in B6 control mice at 3 weeks of infection (table 1) . Similarly, B. burgdorferi-specific antibodies at 60 days of infection were found to be of similar levels for IgG1, IgG2a, and IgM, although IgG2b levels were significantly reduced in IL-6-deficient mice (table 1) , consistent with a lowered Th2 response in these animals.
In conclusion, our data extend our previous in vitro observations indicating a role for IL-6 in the differentiation of IL-4-producing CD4 T cells to an in vivo murine model of bacterial infection and joint inflammation. In addition, these studies further show that murine Lyme arthritis is partially dependent on CD4 T cell responses against B. burgdorferi. IL-6 is, therefore, an important modulator of Th1 and Th2 responses in vivo, which can influence the outcome of microbial infections.
